Abstract P4-12-05: Cost-effectiveness analysis of second-generation multi-gene expression prognostic assays compared with the standard 21-gene recurrence score assay to guide adjuvant therapy decisions in women with early stage breast cancer
2007 ◽
Vol 97
(2)
◽
pp. 152-161
◽
2019 ◽
Vol 20
(1)
◽
pp. 27-46
◽
2013 ◽
Vol 20
(9)
◽
pp. 2873-2880
◽
2009 ◽
Vol 74
(2)
◽
pp. 440-446
◽